OSAIC HOLDINGS, INC. - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 2 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$940,000
+114.1%
53,572
+18.7%
0.00%
+100.0%
Q2 2021$439,000
+8.9%
45,138
+20.2%
0.00%0.0%
Q1 2021$403,000
-20.4%
37,568
+9.4%
0.00%0.0%
Q4 2020$506,000
+154.3%
34,350
+146.1%
0.00%0.0%
Q3 2020$199,000
+268.5%
13,960
+109.6%
0.00%
Q2 2020$54,000
+184.2%
6,660
+42.9%
0.00%
Q1 2020$19,0004,6600.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders